Our top pick for
Building a portfolio
Premier, Inc is a health information services business based in the US. Premier shares (PINC) are listed on the NASDAQ and all prices are listed in US Dollars. Premier employs 2,500 staff and has a trailing 12-month revenue of around USD0.00.
|52-week range||USD$27.67 - USD$37.43|
|50-day moving average||USD$33.92|
|200-day moving average||USD$34.52|
|Wall St. target price||USD$39.19|
|Dividend yield||USD$0.38 (1.09%)|
|Earnings per share (TTM)||USD$2.55|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Premier stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Premier's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Premier's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 14x. In other words, Premier shares trade at around 14x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Premier's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.5957. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Premier's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Premier's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$455.1 million.
The EBITDA is a measure of a Premier's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$1.4 billion|
|Operating margin TTM||21.91%|
|Gross profit TTM||USD$866.8 million|
|Return on assets TTM||6.47%|
|Return on equity TTM||40.72%|
|Market capitalisation||USD$4.3 billion|
TTM: trailing 12 months
There are currently 2.4 million Premier shares held short by investors – that's known as Premier's "short interest". This figure is 15.3% down from 2.8 million last month.
There are a few different ways that this level of interest in shorting Premier shares can be evaluated.
Premier's "short interest ratio" (SIR) is the quantity of Premier shares currently shorted divided by the average quantity of Premier shares traded daily (recently around 622294.22572178). Premier's SIR currently stands at 3.81. In other words for every 100,000 Premier shares traded daily on the market, roughly 3810 shares are currently held short.
However Premier's short interest can also be evaluated against the total number of Premier shares, or, against the total number of tradable Premier shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Premier's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Premier shares in existence, roughly 20 shares are currently held short) or 0.0195% of the tradable shares (for every 100,000 tradable Premier shares, roughly 20 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Premier.
Find out more about how you can short Premier stock.
Dividend payout ratio: 21.66% of net profits
Recently Premier has paid out, on average, around 21.66% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.17% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Premier shareholders could enjoy a 2.17% return on their shares, in the form of dividend payments. In Premier's case, that would currently equate to about $0.38 per share.
While Premier's payout ratio might seem low, this can signify that Premier is investing more in its future growth.
Premier's most recent dividend payout was on 14 March 2021. The latest dividend was paid out to all shareholders who bought their shares by 25 February 2021 (the "ex-dividend date").
Over the last 12 months, Premier's shares have ranged in value from as little as $27.6716 up to $37.4289. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Premier's is 0.2168. This would suggest that Premier's shares are less volatile than average (for this exchange).
Premier, Inc. , together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates through two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and document shredding services. It is also involved in the provision of the ASCEND Collaborative service for members to receive group purchasing programs, tiers, and prices, as well as managed services; SURPASS Collaborative service; STOCKD, an e-commerce platform; and PROVIDEGX program, which identifies supply sources for drugs that are on or may be at risk of being added to the national drug shortage list, or that are vulnerable to pricing volatility, as well as direct sourcing business. The Performance Services segment offers PremierConnect for members to address existing cost and quality imperatives, enable them manage a value-based care reimbursement model, and support their regulatory reporting framework; performance improvement collaborative; and consulting and insurance services. This segment's various PremierConnect domains include PremierConnect Quality & Regulatory, PremierConnect Clinical Surveillance & Safety, PremierConnect Supply Chain & ERP, PremierConnect Operations, PremierConnect Enterprise Analytics, and PREMIERCONNECT Clinical Decision Support domains.
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZION, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZNTL, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZGYH, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZEAL, with 24-hour and historical pricing before you buy.
Steps to owning and managing CTIB, with 24-hour and historical pricing before you buy.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.